SLNO has been in the news 500% more than usual
Nov 12, 2025, 1:32 PM
1.62%
What does SLNO do
Soleno Therapeutics, a clinical-stage biopharmaceutical company based in Redwood City, California, focuses on developing novel therapeutics for rare diseases, notably DCCR for Prader-Willi syndrome. DCCR, a once-daily oral tablet, recently completed Phase 3 trials and has received Fast-Track and orphan designations in the U.S. and EU.
SLNO has been in the news recently: Soleno Therapeutics Inc. announced a share repurchase program and a $100 million accelerated stock repurchase agreement with Jefferies LLC, leading to an increase in its stock price. Additionally, the company is part of a broader mixed performance in U.S. stocks, as the Dow Jones index rose over 100 points on the same day.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.